KCL-286 structure
|
Common Name | KCL-286 | ||
|---|---|---|---|---|
| CAS Number | 1952276-71-9 | Molecular Weight | 334.33 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C19H14N2O4 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of KCL-286Anticancer agent 168 is an orally active retinoic acid receptor (RAR/RXR) beta2 agonist with ameliorating effects on spinal cord injury (SCI)[1]. |
| Name | KCL-286 |
|---|
| Description | Anticancer agent 168 is an orally active retinoic acid receptor (RAR/RXR) beta2 agonist with ameliorating effects on spinal cord injury (SCI)[1]. |
|---|---|
| Related Catalog | |
| Target |
RAR β2[1] |
| References |
| Molecular Formula | C19H14N2O4 |
|---|---|
| Molecular Weight | 334.33 |